Effects of dietary palm olein on the cardiovascular risk factors in healthy young adults

  • Chenyan Lv
  • Yifei Wang
  • Cui Zhou
  • Weiwei Ma
  • Yuexin Yang
  • Rong Xiao
  • Huanling Yu
DOI: https://doi.org/10.29219/fnr.v62.1353
Keywords: palm olein, saturated fatty acids, dietary intervention, replacement, lipid metabolism

Abstract

Background: Dietary saturated fatty acids are always being hotly debated. Palm olein rich in saturated fatty acids (45.98%) is often considered as being atherogenic nutritionally. There is a lack of information on effects of dietary oil by partially replacing with palm olein on human health.

Methods: A randomized controlled trial with 88 participants has been conducted to elucidate the effect of palm olein on cardiovascular risk factors.

Results: By comparing the soybean oil group (saturated fatty acids amounted to 23.31%) with the cocoa butter group (saturated fatty acids amounted to 93.76%), no significant difference was found (p > 0.05) in physiological parameters, serum oxidative stress levels, inflammatory factor, glucose metabolism, and lipid profiles of subjects, which are all cardiovascular risk factors. Although results showed that intervention time can influence the cardiovascular risk factors significantly (p < 0.05), there is no relationship between intervention time and dietary oil type.

Conclusion: Therefore, partial replacement of dietary oil by palm olein may not affect cardiovascular risk factors in healthy young adults. There are differences between our research and previous researches, which may be due to the different amount of palm olien in diet. Our research will provide a solid foundation for the application of palm olein in human diets and in the food industry.

Downloads

Download data is not yet available.

References


  1. Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr 2015; 39(1 Suppl): 18S–32S.

  2. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Biochem Soc T 1995; 87(2): 302–9.

  3. Zuliani G, Galvani M, Leitersdorf E, Volpato S, Cavalieri M, Fellin R. The role of polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias. Curr Pharm Des 2009; 15(36): 4087–93.

  4. Hayes KC, Pronczuk A, Lindsey S, Diersenschade D. Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates. Am J Clin Nutr 1991; 53(2): 491–8.

  5. Iggman D, Riséérus U. Role of different dietary saturated fatty acids for cardiometabolic risk. Clin Lipidol 2011; 6(2): 209–32.

  6. Valsta LM, Tapanainen H, Sundvall J, Laatikainen T, Mannisto S. Explaining the 25year decline of serum cholesterol by dietary changes and use of lipidlowering medication in Finland. Public Health Nutr 2010; 13(6A): 932–8.

  7. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010; 45: 893–905.

  8. Praagman J, Beulens JW, Alssema M, Zock PL, Wanders AJ, Sluijs I, et al. The association between dietary saturated fatty acids and ischemic heart disease depends on the type and source of fatty acid in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Am J Clin Nutr 2016; 103: 475–82.

  9. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism 1965; 14: 776–87.

  10. Malachi O. Palm oil: an over – acclaimed cooking oil in Nigeria. Annu Res Rev Biol 2015; 7(3): 133–43.

  11. Hooper L, Summerbell CD, Higgins JPT, Thompson R, Clements G, Capps N, et al. Reduced or modified dietary fat for preventing cardiovascular disease (Cochrane Review). J Cardiovasc Nurs 2013; 28(3): 204–5.

  12. Jakobsen MU, O’Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89(5): 1425–32.

  13. Tholstrup T, Hjerpsted J, Raff M. Palm olein increases plasma cholesterol moderately compared with olive oil in healthy individuals. Am J Clin Nutr 2011; 94(6): 1426–32.

  14. Fattore E, Fanelli R. Palm oil and palmitic acid: a review on cardiovascular effects and carcinogenicity. Int J Food Sci Nutr 2013; 64(5): 648–59.

  15. Lucci P, Borrero M, Ruiz A, Pacetti D, Frega NG, Diez O. Palm oil and cardiovascular disease: a randomized trial of the effects of hybrid palm oil supplementation on human plasma lipid patterns. Food Funct 2016; 7(1): 347–54.

  16. Filippou A, Teng KT, Berry SE, Sanders TA. Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women. Eur J Clin Nutr 2014; 68: 1036–41.

  17. Tholstrup T, Hjerpsted J, Raff M. Palm olein increases plasma cholesterol moderately compared with olive oil in healthy individuals. Am J Clin Nutr 2011; 94: 1426–32.

  18. Voon PT, Ng TK, Lee VK, Nesaretnam K. Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr 2011; 94: 1451–7.

  19. Hall WL, Brito MF, Huang J, Wood LV, Filippou A, Sanders TA, et al. An interesterified palm olein test meal decreases early-phase postprandial lipemia compared to palm olein: a randomized controlled trial. Lipids 2014; 49: 895–904.

  20. Wei MY, Jacobson TA. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep 2011; 13(6): 474–83.

  21. Hammad KSM, Hallabo SA, Galal SM. Protective effect of linseed oil and walnuts against hypercholesterolemia induced by atherogenic diet in rats. J Food Nutr Res 2015; 3: 653–60.

  22. Oprescu AI, Bikopoulos G, Naassan A, Allister EM, Tang C, Park E, et al. Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes 2007; 56: 2927–37.

  23. Bayorh MA, Abukhalaf IK, Ganafa AA. Effect of palm oil on blood pressure, endothelial function and oxidative stress. Asia Pac J Clin Nutr 2005; 14: 325–39.

  24. Budin SB, Othman F, Louis SR, Bakar MA, Das S, Mohamed J, et al. The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics 2009; 64: 235–44.

  25. Tholstrup T, Teng KT, Raff M. Dietary cocoa butter or refined olive oil does not alter postprandial hsCRP and IL-6 concentrations in healthy women. Lipids 2011; 46: 365–70.

  26. Norhaizan ME, Lee ST, Voon PTNg, Ng TKW, Hazizi AS, Supeng L, et al. Palm based high-oleic cooking oil and extra virgin olive oil diets do not affect markers of insulin resistance and glucose tolerance in overweight adults. J Food Nutr Disord 2016; 5: 5.

  27. Dauqan E, Sani HA, Abdullah A, Kasim ZM. Effect of different vegetable oils (red palm olein, palm olein, corn oil and coconut oil) on lipid profile in rat. Food Nutr Sci 2011; 2: 399–403.

  28. Zock PL, de Vries JH, de Fouw NJ, Katan MB. Positional distribution of fatty acids in dietary triglycerides: effects on fasting blood lipoprotein concentrations in humans. Am J Clin Nutr 1995; 61: 48–55.

  29. Sanders TA, Filippou A, Berry SE, Baumgartner S, Mensink RP. Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr 2011; 94: 1433–41.

  30. San MMI, Collado YL, Cuadrado Cenzual MÁ, Ciudad Cabañas MJ, Mendive DP. Role of apoa1 on high-density lipoproteIn: an intervention with plant sterols in patients with hypercholesterolemia. Nutr Hosp 2014; 31: 494–9.

  31. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, et al. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscl Throm Vas 2004; 24: 1092–7.

  32. Huebbe P, Dose J, Schloesser A, Campbell G, Gluer CC, Gupta Y, et al. Apolipoprotein E (APOE) genotype regulates body weight and fatty acid utilization-Studies in gene-targeted replacement mice. Mol Nutr Food Res 2015; 59: 334–43.

  33. Charnock JS, Abeywardena MY, Mclennan PL. The effect of different dietary lipid supplements on the nonesterified fatty acid composition of normoxic rat hearts: a link between nutrition and cardiac arrhythmia. Nutr Res 1992; 12: 1491–502.

  34. Farsi PF, Djazayery A, Eshraghian MR, Koohdani F, Saboor-Yaraghi AA, Derakhshanian H, et al. Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients. Arq Bras Endocrino 2014; 58: 335–40.

  35. Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen JI. Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. J Lipid Res 1995; 36: 1370–84.

Published
2018-07-16
How to Cite
Lv C., Wang Y., Zhou C., Ma W., Yang Y., Xiao R., & Yu H. (2018). Effects of dietary palm olein on the cardiovascular risk factors in healthy young adults. Food & Nutrition Research, 62. https://doi.org/10.29219/fnr.v62.1353
Issue
Vol 62 (2018)
Section
Original Articles

Authors retain copyright of their work, with first publication rights granted to SNF Swedish Nutrition Foundation. Read the full Copyright- and Licensing Statement.

 

 

Crossref
Scopus
Google Scholar
Europe PMC